title: [The hemoprotective effect of Dicarbamin in ovarian cancer patients receiving chemotherapy].
abstract: The effect of dicarbamin on the hemopoetic cells of the bone marrow of ovarian cancer patients receiving myelosuppressive combination chemotherapy (cyclophosphamide + carboplatin) is discussed.
authors.affiliation: N.N. Blokhin Center for Oncology Research, Russian Academy of Medical Sciences, Moscow.
authors.forename: N T
authors.initials: NT
authors.lastname: Raĭkhlin
authors.forename: V A
authors.initials: VA
authors.lastname: Gorbunova
authors.forename: E M
authors.initials: EM
authors.lastname: Treshchalina
authors.forename: M B
authors.initials: MB
authors.lastname: Bychkov
authors.forename: E A
authors.initials: EA
authors.lastname: Smirnova
authors.forename: N V
authors.initials: NV
authors.lastname: Mindra
authors.forename: S V
authors.initials: SV
authors.lastname: Topchieva
authors.forename: G N
authors.initials: GN
authors.lastname: Zubrikhina
authors.forename: V E
authors.initials: VE
authors.lastname: Nebol'sin
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects*; D001854:Bone Marrow Cells / Q000187:drug effects* / Q000648:ultrastructure; D002208:Caproates; D016190:Carboplatin / Q000009:adverse effects; D003520:Cyclophosphamide / Q000009:adverse effects; D004334:Drug Administration Schedule; D005260:Female; D006402:Hematologic Diseases / Q000139:chemically induced / Q000517:prevention & control*; D006410:Hematopoiesis / Q000187:drug effects*; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology* / Q000627:therapeutic use*; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D002208:Caproates; D007093:Imidazoles; C539419:pentanedioic acid imidazolyl ethanamide; D003520:Cyclophosphamide; D016190:Carboplatin